We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current N4P market cap is 1.41M. The company's latest EPS is GBP -0.0047 and P/E is -1.11.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 2k |
| Operating Income | -947k | -1.56M | -1.84M | -1.19M | -1.34M |
| Net Income | -876k | -1.31M | -1.54M | -1.03M | -1.27M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 1.07M | 3.83M | 2.34M | 2.17M | 1.28M |
| Total Liabilities | 78k | 169k | 212k | 78k | 81k |
| Total Equity | 987k | 3.66M | 2.13M | 2.09M | 1.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -806k | -1.38M | -1.77M | -828k | -1.21M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 979k | 3.97M | 1,000 | 964k | 316k |
| Market Cap | 1.41M |
| Price to Earnings Ratio | -1.11 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.37 |
| Price to Book Ratio | 1.17 |
| Dividend Yield | - |
| Shares Outstanding | 268.78M |
| Average Volume (1 week) | 422.27k |
| Average Volume (1 Month) | 472.15k |
| 52 Week Change | -70.83% |
| 52 Week High | 1.80 |
| 52 Week Low | 0.412 |
| Spread (Intraday) | 0.05 (9.09%) |
| Company Name | N4 Pharma Plc |
| Address |
6 th floor derbyshire EC3V 0HR |
| Website | https://www.n4pharma.com |
| Industry | computer & office equipment (3570) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
